WuXi STA, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has announced the ope...
Bora Pharmaceutical Laboratories Inc. (Zhunan), a division of Bora Pharmaceuticals has partnered with TaiRx, Inc., a Tai...
Great Bay Bio (GBB), Hong Kong-based startup, has announced the completion of its $15 million Pre-series B funding ...
Catalent, the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize development, lau...
AcuraBio (formerly Luina Bio), a leading Australian biopharmaceutical CDMO, has been acquired by biotech investor Dr Gle...
China's WuXi Biologics, a global leading Contract Research, Development and Manufacturing Organization (CRDMO), has anno...
WuXi Advanced Therapies (WuXi ATU), a wholly owned subsidiary of China-based WuXi AppTec, has announced a licensing agre...
BioDuro-Sundia, an industry-leading drug discovery, development and commercial service contract research development and...
The COVID-19 pandemic highlighted the successful development and utilisation of mRNA vaccines. This has encouraged bioph...
WuXi Biologics, a global leading Contract Research, Development and Manufacturing Organization (CRDMO), has announced a ...
Samsung Biologics, a South Korea-based contract development and manufacturing organization (CDMO), has signed a land pur...
TFBS Bioscience Inc., the leading GMP viral vector contract development and manufacturing organization in the Asia-Pacif...
GenScript ProBio, a global CDMO, and South Korea-based startup DAAN Bio Therapeutics, have entered into a strategic...
Amaran Biotechnology Inc., a subsidiary of Taiwan's OBI Pharma Inc., has completed the construction of it...
WuXi STA, a subsidiary of China-based WuXi AppTec, has announced the opening of a new large-scale oligonucleotide and pe...
Next milestone for the site development is achieved Positive feedback recei...
Japan-based Fujifilm Corporation has announced the investment of $1.6 billion to enhance and expand the cell culture man...
WuXi STA, a WuXi AppTec company, has opened another high-potency API (HPAPI) plant at its Changzhou site (Jiangsu, China...
Companies in the pharmaceutical sector have been facing fierce competition, cost pressure, technological innovations, an...
Eurofins DiscoverX Products LLC, a global industry leader in products for small and large molecule drug discovery a...
Merck has announced that its Life Science business sector has doubled its high-potent active pharmaceutical ingredients ...
WuXi Biologics, a global contract research, development and manufacturing organisation (CRDMO) service company, has succ...
South Korea-based Hanmi Fine Chemical, a subsidiary of Hanmi Pharmaceutical Group specializing in APIs (Active Pharmaceu...
Senator h.c. Udo J. Vetter, Chairman of the Advisory Board and member of the owner family (second from left) along with ...
South Korean firm LOTTE has agreed to purchase Bristol Myers Squibb’s manufacturing facility in East Syracuse, New...
GenScript ProBio, a global CDMO company from GenScript Biotech Corporation, has announced the opening of a legal entity ...
Taiwan-based contract development and manufacturing organization (CDMO) Bora Pharmaceuticals has recently announced the ...
Avantor, Inc. has announced that it will create a new manufacturing and distribution Hub in Singapore, by integrating it...
Japan-based Asahi Kasei Medical has concluded an agreement through a US subsidiary to wholly acquire Bionova S...
Thermo Fisher Scientific has opened its new single-use technology manufacturing site in Ogden, Utah in the US. The state...
GC corp., the holding (system) company for GC group in South Korea with major operating companies across healthcare se...
US-based VectorBuilder Inc. has announced the construction of a new R&D and manufacturing centre in Guangzhou, China...
CHA Medical & Bio Group officially began construction of its Cell Gene Biobank (CGB) facility in Pangyo, South Korea...
Exothera was founded in 2020 to help tackle two of the most critical challenges manufacturers face in bringing adva...
Japan-based FUJIFILM Corporation has announced that FUJIFILM Irvine Scientific, Inc., a world leader in the development ...
WuXi Advanced Therapies (WuXi ATU), a wholly owned subsidiary of WuXi AppTec, announced the launch of Tetracycline-Enabl...
Vetter’s high-level performance further substantiates its dedicated performance in customer-critical services R...
The World Health Organization (WHO), the Republic of Korea and the WHO Academy have announced the establishment of a glo...
Moderna, Inc. and Thermo Fisher Scientific Inc. have announced a 15-year strategic collaboration agreement to enable ded...
US-based Catalent, the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize develop...
US-based Avantor, Inc. has started construction on a distribution centre which will help expedite access to essential pr...
GenScript Biotech Corporation has announced the opening of a new facility for highly automated protein and gene pr...
New South Wales (NSW) will leverage its world-class cell and gene therapy expertise to establish Australia’s first...
South Korea-based Samsung Biologics has reached an agreement with Biogen for the buyout of Biogen's stake in the Sa...
Atara Biotherapeutics, Inc. has entered into a long term strategic agreement with FUJIFILM Diosynth Biotechnologies...
WuXi STA, a subsidiary of WuXi AppTec, has announced that its first parenteral formulation manufacturing line ...
GenScript ProBio, a global antibody and gene therapy contract development and manufacturing organization (CDMO), has ann...
Important milestone reached for the new site Additional filling capacities for early-stage clinical development Firs...
The Centre for Breakthrough Medicines (CBM), based in the US, has received $350 million in equity financing from South K...
The inauguration ceremony of Biosyngen joint projects and Biosyngen biological production base was held recently in ...
Novavax, Inc. and SK bioscience, Co. Limited, a vaccine business subsidiary of Korea-based SK Group, have announced the ...
Curocell, currently on PhaseⅠCAR-T Therapy clinical trial with CRC01 (anbalcabtagene autoleucel), has recently broken ...
South Korea-based Samsung Biologics continues its strategic biopharmaceutical manufacturing collaboration with AstraZene...
GenScript ProBio, the biologics contract development and manufacturing organisation (CDMO) segment of US-based GenScript...
Taiwan-based Bora Pharmaceuticals has announced a partnership with Taishin Healthcare whereby the two parties will joint...
Significant role in customer success Recognition for quality, innovation and loyalty as a strategic partner for asept...
FUJIFILM Irvine Scientific, Inc. has announced the establishment of an Innovation and Collaboration Centre in Suzhou New...
China-based WuXi STA, a subsidiary of WuXi AppTec, and Coherent Biopharma, have announced the signing of a strategic par...
ST Pharm Co. Ltd., an Active Pharmaceutical Ingredient (API) contract development and manufacturing organization (CDMO) ...
From playing a central role in combatting COVID-19 to producing the small or individual batches required in personalized...
Japan-based Meiji Seika Pharma has announced that it has been decided to construct a new manufacturing facility at Adcoc...
Japan-based Yokogawa Electric Corporation has acquired all shares of Insilico Biotechnology AG, a Germany-based develope...
WuXi Biologics has successfully launched the GMP operation of its new drug product facility located in Wuxi, China,...
MilliporeSigma, the U.S. and Canadian Life Science business of Merck KGaA, Darmstadt, Germany, a leading science an...
The 6,000 square-meter site will provide flexible clinical supply solutions, serving both local and global biotech and p...
Cytiva continues to expand its manufacturing capacity for bioprocessing single-use consumables in China. In collaboratio...
GeneQuine is developing GQ-303, its intraarticular gene therapy candidate, which turns joint cells into factories for pr...
Thermo Fisher Scientific Inc. has announced plans to establish a manufacturing facility in Nashville, US ...
ExoCoBio Inc. has announced the initiation of its "Project EGMP", starting with the construction of the world's first ex...
Expansion of clinical capacity to address growing market demand Site status now ‘ready for media fill’ N...
FUJIFILM Corporation, based in Japan, has announced a ¥90 Billion Yen (~$850 Million) investment package to accelera...
Samsung Biologics, the world's leading contract development and manufacturing organization, signed a strategic partnersh...
Samsung Biologics, a South Korea-based contract development and manufacturing organization (CDMO), has announced it...
Moderna and Samsung Biologics, a leading global CDMO providing a fully integrated end-to-end contract development and ma...
China based WuXi Biologics, a contract development and manufacturing organization (CDMO) with leading open-access b...
" Germany- based Vetter, one of the global leaders in prefilled drug-delivery systems, has announced the opening of...
Cytiva, a global life sciences leader, will provide another FlexFactory platform for Chinese biopharmaceutical company, ...
Avantor Inc., a leading global provider of mission-critical products and services to customers in the life sciences, adv...
South Korea based Samsung Biologics, the world’s leading contract development and manufacturing organization and U...
Sanofi has announced a €400 million investment over five years to create a unique vaccine production center in Sing...
Corden Pharma of Germany has entered into a technology alliance agreement with Nanos, based in South Korea, relating to ...
Waters Corporation introduced a new peptide multi-attribute method (MAM) workflow for the Waters™ BioAccord&t...
FUJIFILM Corporation has announced the selection of Holly Springs, North Carolina as the location for its...
Australian Minister for Industry, Science and Technology, Hon Karen Andrews MP on March, 11, 2021 launched a new $30 mil...
WuXi Biologics, a global company with leading open-access biologics technology platforms, has announced that it has ente...
§ Vetter reaffirms its high performance in customer-critical aspects § Results reflect the positi...
Bristol Myers Squibb and WuXi STA – a subsidiary of WuXi AppTec – have announced that WuXi ST...
Exothera S.A., a full-service Contract Development and Manufacturing Organization (CDMO) delivering customized proc...
Thermo Fisher Scientific Inc. and Groupe Novasep SAS, a leading supplier of services and technologies for the life scien...
Samsung Biologics set forth its dynamic growth plan for the next decade at the 2021 Annual JP Morgan Healthcare Co...
FUJIFILM Corporation is making an investment of more than 200 Billion yen ($2 Billion) to establish a new...
Japanese firm Sosei Group Corporation has announced that it has entered into a global collaboration and license agr...
Japanese firm Sosei Group Corporation has announced that it has entered into a global collaboration and license agr...
Samsung Biologics has officially begun construction of its Plant 4 in Incheon, South Korea. Dubbed the "Super Plant...
South Korea based Samsung Biologics' partnership with Eli Lilly and Company is expected to greatly accelerate the global...
Merck has announced a strategic technology collaboration with Transcenta, a global biotherapeutics company headquartered...
China's Porton Biologics is committed to building an end-to-end gene and cell therapy CDMO service platform. The Op...
Thermo Fisher Scientific and Symphogen, an affiliate of and the antibody center of excellence within the international p...
Merck has recently announced a collaboration with Mammoth Biosciences Inc. of South San Francisco, California, USA, for ...
Avidity Science, a leader in water purification and delivery, control and monitoring and service solutions for the ...
